Statements of Stockholders' Equity (Deficit) - USD ($)	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2022	$ 4,084,649	$ 28	$ 119,731,764	$ (115,647,143)
Beginning Balance, Shares at Dec. 31, 2022		278,558
Stock-based compensation expense	1,128,109		1,128,109
Net loss	(7,792,295)			(7,792,295)
Ending Balance at Dec. 31, 2023	$ (2,579,537)	$ 28	120,859,873	(123,439,438)
Ending Balance, Shares at Dec. 31, 2023	278,558	278,558
Stock-based compensation expense	$ 773,121		773,121
Issuance of common stock, Pre-Funded Warrants, Series A Warrants, Series B Warrants, and Series C Warrants net of issuance costs	6,172,623	$ 43	6,172,580
Issuance of common stock, Pre-Funded Warrants, Series A Warrants, Series B Warrants, and Series C Warrants net of issuance costs, shares		427,886
Amendment and issuance of common stock from Amendment of Series B Warrants and Series C Warrants, net of issuance costs	1,229,874	$ 1	1,229,873
Amendment and issuance of common stock from Amendment of Series B Warrants and Series C Warrants, net of issuance costs, shares		9,967
Amendment and issuance of Pre-Funded Warrants from Amendment of Series B Warrants and Series C Warrants, net of issuance costs	308,429		308,429
Amendment and issuance of common stock from Exercise Price Warrant Amendment of Series A Warrants and Series Warrants, net of issuance costs	2,532,449	$ 3	2,532,446
Amendment and issuance of common stock from Exercise Price Warrant Amendment of Series A Warrants and Series Warrants, net of issuance costs, shares		24,509
Amendment and issuance of common stock from Amendment of Series B Warrants and Series C Warrants, net of issuance costs	370,622	$ 5	370,617
Amendment and issuance of common stock from Amendment of Series B Warrants and Series C Warrants, net of issuance costs, shares		51,062
Issuance of common stock from the exercise of Pre-Funded Warrants, Series A Warrants, Series B Warrants, and Series C Warrants net of issuance costs	3,582,814	$ 58	3,582,756
Issuance of common stock from the exercise of Pre-Funded Warrants, Series A Warrants, Series B Warrants, and Series C Warrants net of issuance costs, shares		583,657
Issuance of common stock from cashless exercise of pre-funded warrants, shares		110,370
Issuance of common stock from cashless exercise of pre-funded warrants		$ 11	(11)
Redemption of fractional shares due to reverse stock split	(191)		(191)
Net loss	(5,352,194)			(5,352,194)
Ending Balance at Dec. 31, 2024	$ 7,038,010	$ 149	$ 135,829,493	$ (128,791,632)
Ending Balance, Shares at Dec. 31, 2024	1,486,009	1,486,009